Show Summary Details
Page of

Upper Gastrointestinal Bleeding 

Upper Gastrointestinal Bleeding
Upper Gastrointestinal Bleeding

S Chandra

, Su Min Cho

, and Ali Al-Khafaji

Page of

PRINTED FROM OXFORD MEDICINE ONLINE ( © Oxford University Press, 2016. All Rights Reserved. Under the terms of the licence agreement, an individual user may print out a PDF of a single chapter of a title in Oxford Medicine Online for personal use (for details see Privacy Policy and Legal Notice).

date: 20 February 2020

Upper gastrointestinal bleeding (UGIB) is a major cause of morbidity and mortality in patients with end-stage liver disease (ESLD) and in majority of the cases is a direct consequence of portal hypertension (PH). Despite improvements in therapeutic options and supportive therapy, the 6-week mortality rate remains high: from 15% to 30% in patients with Child class C. The annual incidence of UGIB in patients with cirrhosis and PH is approximately 25% to 35% per year.

Esophageal and gastric variceal bleeding accounts for the majority of episodes of UGIB in patients with cirrhosis. In a study of 465 patients with cirrhosis, the etiology for UGIB was esophageal varices (64%), gastric varices (8.4%), portal hypertensive gastropathy (9.5%), and peptic ulcer disease (7.5%), with esophagitis, erosions, and esophageal ulcers accounting for the rest.

Access to the complete content on Oxford Medicine Online requires a subscription or purchase. Public users are able to search the site and view the abstracts for each book and chapter without a subscription.

Please subscribe or login to access full text content.

If you have purchased a print title that contains an access token, please see the token for information about how to register your code.

For questions on access or troubleshooting, please check our FAQs, and if you can't find the answer there, please contact us.